The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H-pylori eradication and duodenal ulcer healing

Sivri, B; Simsek, K; Hulagu, S; Kadayifci, A; Tozun, N; Akarsu, M; Uraz, S; Savas, MC; Koruk, M; Bozbas, A

doi:10.1185/030079904125004439

The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H-pylori eradication and duodenal ulcer healing

Copy For Citation

Sivri B., Simsek K., Hulagu S., Kadayifci A., Tozun N., Akarsu M., ...More

CURRENT MEDICAL RESEARCH AND OPINION, vol.20, no.8, pp.1301-1307, 2004 (SCI-Expanded)

Publication Type: Article / Article
Volume: 20 Issue: 8
Publication Date: 2004
Doi Number: 10.1185/030079904125004439
Journal Name: CURRENT MEDICAL RESEARCH AND OPINION
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1301-1307
Hacettepe University Affiliated: No

Abstract

Objective: Recently, proton pump inhibitor (PPI)-based triple therapy has been recommended as a first line treatment in the eradication of Helicobacter pylori. The aim of this open, multicentre trial was to investigate the efficacy, safety, tolerability and the ulcer healing rate of a triple regimen consisting of pantoprazole(.) 40 mg, clarithromycin 500 mg and amoxicillin 1000 mg twice daily for 7 days, in the eradication of H. pylori in patients with duodenal ulcer in Turkey.